The role of aquaporin-4 in cerebral water transport and edema

Orin Bloch, Geoffrey T. Manley

Research output: Contribution to journalArticle

65 Citations (Scopus)

Abstract

Despite decades of research into the pathogenesis of cerebral edema, nonsurgical therapy for brain swelling has advanced very little after more than half a century. Recent advancements in our understanding of molecular water transport have generated interest in new targets for edema therapy. Aquaporin-4 (AQP4) is the primary cellular water channel in the brain, localized to astrocytic foot processes along the blood-brain barrier and brain-cerebrospinal fluid interface. Multiple studies of transgenic mice with a complete deficiency or altered expression of AQP4 suggest a prominent role for AQP4 in cerebral water transport. In models of cellular (cytotoxic) edema, AQP4 deletion or alteration has been shown to be protective, reducing edema burden and improving overall survival. In contrast, AQP4 deletion in extracellular (vasogenic) edema results in decreased edema clearance and greater progression of disease. The data strongly support the conclusion that AQP4 plays a pivotal role in cerebral water transport and is an essential mediator in the formation and resorption of edema fluid from the brain parenchyma. These findings also suggest that drug therapy targeting AQP4 function and expression may dramatically alter our ability to treat cerebral edema.

Original languageEnglish (US)
Article numberE3
JournalNeurosurgical Focus
Volume22
Issue number5
StatePublished - Jan 1 2007
Externally publishedYes

Fingerprint

Aquaporin 4
Brain Edema
Edema
Water
Aquaporins
Brain
Drug Delivery Systems
Blood-Brain Barrier
Transgenic Mice
Cerebrospinal Fluid
Disease Progression
Foot
Drug Therapy
Therapeutics

Keywords

  • Aquaporin
  • Cerebral edema
  • Cytotoxicity
  • Vasogenic edema
  • Water channel

ASJC Scopus subject areas

  • Surgery
  • Clinical Neurology

Cite this

The role of aquaporin-4 in cerebral water transport and edema. / Bloch, Orin; Manley, Geoffrey T.

In: Neurosurgical Focus, Vol. 22, No. 5, E3, 01.01.2007.

Research output: Contribution to journalArticle

@article{1b1a23bee8d74cc69840c0d3f7be5be6,
title = "The role of aquaporin-4 in cerebral water transport and edema",
abstract = "Despite decades of research into the pathogenesis of cerebral edema, nonsurgical therapy for brain swelling has advanced very little after more than half a century. Recent advancements in our understanding of molecular water transport have generated interest in new targets for edema therapy. Aquaporin-4 (AQP4) is the primary cellular water channel in the brain, localized to astrocytic foot processes along the blood-brain barrier and brain-cerebrospinal fluid interface. Multiple studies of transgenic mice with a complete deficiency or altered expression of AQP4 suggest a prominent role for AQP4 in cerebral water transport. In models of cellular (cytotoxic) edema, AQP4 deletion or alteration has been shown to be protective, reducing edema burden and improving overall survival. In contrast, AQP4 deletion in extracellular (vasogenic) edema results in decreased edema clearance and greater progression of disease. The data strongly support the conclusion that AQP4 plays a pivotal role in cerebral water transport and is an essential mediator in the formation and resorption of edema fluid from the brain parenchyma. These findings also suggest that drug therapy targeting AQP4 function and expression may dramatically alter our ability to treat cerebral edema.",
keywords = "Aquaporin, Cerebral edema, Cytotoxicity, Vasogenic edema, Water channel",
author = "Orin Bloch and Manley, {Geoffrey T.}",
year = "2007",
month = "1",
day = "1",
language = "English (US)",
volume = "22",
journal = "Neurosurgical Focus",
issn = "1092-0684",
publisher = "American Association of Neurological Surgeons",
number = "5",

}

TY - JOUR

T1 - The role of aquaporin-4 in cerebral water transport and edema

AU - Bloch, Orin

AU - Manley, Geoffrey T.

PY - 2007/1/1

Y1 - 2007/1/1

N2 - Despite decades of research into the pathogenesis of cerebral edema, nonsurgical therapy for brain swelling has advanced very little after more than half a century. Recent advancements in our understanding of molecular water transport have generated interest in new targets for edema therapy. Aquaporin-4 (AQP4) is the primary cellular water channel in the brain, localized to astrocytic foot processes along the blood-brain barrier and brain-cerebrospinal fluid interface. Multiple studies of transgenic mice with a complete deficiency or altered expression of AQP4 suggest a prominent role for AQP4 in cerebral water transport. In models of cellular (cytotoxic) edema, AQP4 deletion or alteration has been shown to be protective, reducing edema burden and improving overall survival. In contrast, AQP4 deletion in extracellular (vasogenic) edema results in decreased edema clearance and greater progression of disease. The data strongly support the conclusion that AQP4 plays a pivotal role in cerebral water transport and is an essential mediator in the formation and resorption of edema fluid from the brain parenchyma. These findings also suggest that drug therapy targeting AQP4 function and expression may dramatically alter our ability to treat cerebral edema.

AB - Despite decades of research into the pathogenesis of cerebral edema, nonsurgical therapy for brain swelling has advanced very little after more than half a century. Recent advancements in our understanding of molecular water transport have generated interest in new targets for edema therapy. Aquaporin-4 (AQP4) is the primary cellular water channel in the brain, localized to astrocytic foot processes along the blood-brain barrier and brain-cerebrospinal fluid interface. Multiple studies of transgenic mice with a complete deficiency or altered expression of AQP4 suggest a prominent role for AQP4 in cerebral water transport. In models of cellular (cytotoxic) edema, AQP4 deletion or alteration has been shown to be protective, reducing edema burden and improving overall survival. In contrast, AQP4 deletion in extracellular (vasogenic) edema results in decreased edema clearance and greater progression of disease. The data strongly support the conclusion that AQP4 plays a pivotal role in cerebral water transport and is an essential mediator in the formation and resorption of edema fluid from the brain parenchyma. These findings also suggest that drug therapy targeting AQP4 function and expression may dramatically alter our ability to treat cerebral edema.

KW - Aquaporin

KW - Cerebral edema

KW - Cytotoxicity

KW - Vasogenic edema

KW - Water channel

UR - http://www.scopus.com/inward/record.url?scp=34547786737&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34547786737&partnerID=8YFLogxK

M3 - Article

C2 - 17613234

AN - SCOPUS:34547786737

VL - 22

JO - Neurosurgical Focus

JF - Neurosurgical Focus

SN - 1092-0684

IS - 5

M1 - E3

ER -